Could a common steroid boost survival after severe stroke? new trial aims to find out
NCT ID NCT07202143
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 24 times
Summary
This study tests whether adding the steroid methylprednisolone to standard clot-removal treatment can improve survival and recovery in people who have had a severe stroke with a large brain clot and low immune cell counts. About 200 participants will receive either the steroid or a placebo, and researchers will compare outcomes after 90 days. The goal is to see if this approach is at least as good as standard care for reducing death and disability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE INFARCT CORE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, the First Affiliated Hospital Fujian Medical University
RECRUITINGFuzhou, Fujian, 350005, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.